Literature DB >> 11125829

A short and efficient transformation of rhamnose into activated daunosamine, acosamine, ristosamine and epi-daunosamine derivatives, and synthesis of an anthracycline antibiotic acosaminyl-epsilon-iso-rhodomycinone.

B Renneberg1, Y M Li, H Laatsch, H H Fiebig.   

Abstract

3-Amino-2,3,6-trideoxyhexopyranoses are essential constituents of most anthracycline antitumour antibiotics. For an investigation of structure-activity relationships, the four diastereomeric amino sugars daunosamine, acosamine, ristosamine, and epi-daunosamine were synthesised in short and efficient routes starting from commercially available rhamnose. Several glycosyl donors were provided and their use was exemplified in the synthesis of acosaminyl-epsilon-isorhodomycinone.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11125829     DOI: 10.1016/s0008-6215(00)00257-3

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  4 in total

1.  The structure of anthracycline derivatives determines their subcellular localization and cytotoxic activity.

Authors:  Pazit Shaul; Michael Frenkel; Elinor Briner Goldstein; Leonid Mittelman; Assaf Grunwald; Yuval Ebenstein; Ilan Tsarfaty; Micha Fridman
Journal:  ACS Med Chem Lett       Date:  2013-02-04       Impact factor: 4.345

2.  Targeting anthracycline-resistant tumor cells with synthetic aloe-emodin glycosides.

Authors:  Elinor Breiner-Goldstein; Zoharia Evron; Michael Frenkel; Keren Cohen; Keren Nir Meiron; Dan Peer; Yael Roichman; Eliezer Flescher; Micha Fridman
Journal:  ACS Med Chem Lett       Date:  2011-05-12       Impact factor: 4.345

3.  Synthesis and DNA-binding affinity studies of glycosylated intercalators designed as functional mimics of the anthracycline antibiotics.

Authors:  Wei Shi; Robert S Coleman; Todd L Lowary
Journal:  Org Biomol Chem       Date:  2009-07-17       Impact factor: 3.876

4.  Synthetic (N,N-Dimethyl)doxorubicin Glycosyl Diastereomers to Dissect Modes of Action of Anthracycline Anticancer Drugs.

Authors:  Dennis P A Wander; Sabina Y van der Zanden; Merijn B L Vriends; Branca C van Veen; Joey G C Vlaming; Thomas Bruyning; Thomas Hansen; Gijsbert A van der Marel; Herman S Overkleeft; Jacques J C Neefjes; Jeroen D C Codée
Journal:  J Org Chem       Date:  2021-03-30       Impact factor: 4.354

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.